EXTH-25. EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) AND TEMOZOLOMIDE IN MGMT EXPRESSING AND NON-EXPRESSING PATIENT-DERIVED GLIOBLASTOMA CELLS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details